PubMed:33113325 / 920-1109 JSONTXT

{"project":"LitCovid_Glycan-Motif-Structure","denotations":[{"id":"T1","span":{"begin":130,"end":137},"obj":"https://glytoucan.org/Structures/Glycans/G00021MO"},{"id":"T2","span":{"begin":130,"end":137},"obj":"https://glytoucan.org/Structures/Glycans/G54161DR"}],"text":"Treatment consisted of respiratory support, extracorporeal blood purification using the AN69ST (oXiris®) hemofilter, and 300 U/kg heparin to maintain activation clotting time ≥ 180 seconds."}

{"project":"Inflammaging","denotations":[{"id":"T8","span":{"begin":0,"end":189},"obj":"Sentence"},{"id":"T8","span":{"begin":0,"end":189},"obj":"Sentence"}],"text":"Treatment consisted of respiratory support, extracorporeal blood purification using the AN69ST (oXiris®) hemofilter, and 300 U/kg heparin to maintain activation clotting time ≥ 180 seconds."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T9","span":{"begin":59,"end":64},"obj":"Body_part"},{"id":"T10","span":{"begin":130,"end":137},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma82839"}],"text":"Treatment consisted of respiratory support, extracorporeal blood purification using the AN69ST (oXiris®) hemofilter, and 300 U/kg heparin to maintain activation clotting time ≥ 180 seconds."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T3","span":{"begin":59,"end":64},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"Treatment consisted of respiratory support, extracorporeal blood purification using the AN69ST (oXiris®) hemofilter, and 300 U/kg heparin to maintain activation clotting time ≥ 180 seconds."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T8","span":{"begin":59,"end":64},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T9","span":{"begin":59,"end":64},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T10","span":{"begin":150,"end":160},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"Treatment consisted of respiratory support, extracorporeal blood purification using the AN69ST (oXiris®) hemofilter, and 300 U/kg heparin to maintain activation clotting time ≥ 180 seconds."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T7","span":{"begin":130,"end":137},"obj":"Chemical"}],"attributes":[{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"}],"text":"Treatment consisted of respiratory support, extracorporeal blood purification using the AN69ST (oXiris®) hemofilter, and 300 U/kg heparin to maintain activation clotting time ≥ 180 seconds."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T5","span":{"begin":161,"end":169},"obj":"http://purl.obolibrary.org/obo/GO_0050817"}],"text":"Treatment consisted of respiratory support, extracorporeal blood purification using the AN69ST (oXiris®) hemofilter, and 300 U/kg heparin to maintain activation clotting time ≥ 180 seconds."}

{"project":"LitCovid-PubTator","denotations":[{"id":"50","span":{"begin":130,"end":137},"obj":"Chemical"}],"attributes":[{"id":"A50","pred":"tao:has_database_id","subj":"50","obj":"MESH:D006493"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Treatment consisted of respiratory support, extracorporeal blood purification using the AN69ST (oXiris®) hemofilter, and 300 U/kg heparin to maintain activation clotting time ≥ 180 seconds."}

{"project":"LitCovid-sentences","denotations":[{"id":"T8","span":{"begin":0,"end":189},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Treatment consisted of respiratory support, extracorporeal blood purification using the AN69ST (oXiris®) hemofilter, and 300 U/kg heparin to maintain activation clotting time ≥ 180 seconds."}